PIQRAY

Product Overview

About PIQRAY

PIQRAY is a medicine that contains the active ingredient ALPELISIB, which is used to treat certain types of breast cancer. Specifically, PIQRAY is designed for the treatment of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. The medication works by inhibiting the PI3K pathway, which is involved in the growth and spread of cancer cells.

Key Benefits & Uses

• Treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women
• Inhibition of the PI3K pathway to reduce cancer cell growth and proliferation
• Improvement of progression-free survival in patients with this specific type of breast cancer

Active Ingredient & Action

ALPELISIB, the active ingredient in PIQRAY, is a phosphatidylinositol 3-kinase (PI3K) inhibitor. It works by blocking the activity of the PI3K enzyme, which is involved in the signaling pathways that promote cell growth and survival. By inhibiting this enzyme, ALPELISIB helps to reduce the growth and spread of cancer cells, thereby slowing down the progression of the disease.

Important Notes

Patients taking PIQRAY should be monitored for potential side effects and interactions with other medications. It is essential to follow the prescribed dosage and treatment schedule to minimize the risk of adverse effects. Additionally, patients should discuss their medical history and any concerns with their healthcare provider before starting treatment with PIQRAY.